TD Asset Management’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-122,000
Closed -$2.38M 1498
2022
Q4
$2.38M Hold
122,000
﹤0.01% 934
2022
Q3
$2.57M Hold
122,000
﹤0.01% 923
2022
Q2
$3.91M Hold
122,000
﹤0.01% 829
2022
Q1
$4.97M Hold
122,000
﹤0.01% 824
2021
Q4
$5.45M Hold
122,000
﹤0.01% 845
2021
Q3
$6.08M Buy
122,000
+92,000
+307% +$4.79M 0.01% 775
2021
Q2
$1.66M Buy
+30,000
New +$1.51M ﹤0.01% 1148

TD Asset Management's ELAT Position: Q1 2023 in Review

TD Asset Management sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 122,000 shares — an estimated $2.38M sold.

TD Asset Management first reported a position in ELAT in Q2 2021 and held it in 7 quarters. The position peaked at $6.08M in Q3 2021. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

  • TD Asset Management reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
  • TD Asset Management sold 122,000 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $2.38M.
  • TD Asset Management first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q2 2021 and held it in 7 quarters.
  • TD Asset Management's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $6.08M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.